Rhonda Patrick· PhD
Dr. Harris highlights the relative safety of even high-dose omega-3, and why dose is crucial in designing successful trials.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Dr. Harris highlights the relative safety of even high-dose omega-3, and why dose is crucial in designing successful trials.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so that's probably why the dos studies we'll talk about high dose has been effective because you at least hit them with a bigger hammer